Fulvestrant ('Faslodex')--a new treatment option for patients progressing on prior endocrine therapy.
Citations
158 citations
146 citations
Cites background from "Fulvestrant ('Faslodex')--a new tre..."
...estrogen receptor modulators (SERMs) such as arzoxifene, with more favorable tissue-specific ER effects than tamoxifen [59], as well as selective ER downregulators (SERDs) such as the potent antiestrogen fulvestrant (Faslodex, ICI 182,780), which target and degrade the ER [60, 71], are already in clinical use or at the final stages of clinical development....
[...]
143 citations
101 citations
Cites background from "Fulvestrant ('Faslodex')--a new tre..."
...These tumours often remain ERa positive and may respond to an alternative endocrine agent, showing ERa-dependence for the continued growth of these tumours (Buzdar and Howell, 2001; Morris and Wakeling, 2002), and indicating altered ERa function as a possible mechanism underlying treatment failure....
[...]
...…tumours often remain ERα positive and may respond to an alternative endocrine agent, demonstrating ERα-dependence for the continued growth of these tumours (Buzdar and Howell, 2001; Morris and Wakeling, 2002), and indicating altered ERα function as a possible mechanism underlying treatment failure....
[...]
98 citations
References
979 citations
836 citations
"Fulvestrant ('Faslodex')--a new tre..." refers background in this paper
...Both the third-generation, non-steroidal AIs, anastrozole (‘Arimidex’) and letrozole, have efficacy advantages over tamoxifen in postmenopausal patients as first-line therapy (Bonneterre et al. 2000, Nabholtz et al. 2000, Mouridsen et al. 2001)....
[...]
...Anastrozole also demonstrates a safety advantage over tamoxifen (Bonneterre et al. 2000)....
[...]
654 citations
644 citations
"Fulvestrant ('Faslodex')--a new tre..." refers background in this paper
...The estrogen-agonist properties of tamoxifen can generate positive effects in some tissues: in blood it may help reduce serum cholesterol, and in bone tamoxifen helps to maintain bone mineral density (Chang et al. 1996, Powles et al. 1996)....
[...]
636 citations
"Fulvestrant ('Faslodex')--a new tre..." refers background in this paper
...These AIs are more effective than megestrol acetate after progression on tamoxifen (Buzdar et al. 1998, Dombernowsky et al. 1998)....
[...]